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Abstract
Immunoglobulin G4–related disease (IgG4-RD) is a chronic fibrosing inflammatory systemic disorder that has been recognized
relatively recently in the medical literature. Little is known about the exact disease pathogenesis and epidemiology. IgG4RD may be asymptomatic or may have minimal symptoms or involve multiple organs with overt symptoms. The different
phenotypes of IgG4-RD can lead to delayed or incorrect diagnosis. We report the case of a 66-year-old male with coal
worker’s pneumoconiosis who presented with progressive kidney disease and was diagnosed with tubulointerstitial nephritis
due to IgG4-RD. The patient was noted to have progressive kidney disease, skin involvement, worsening interstitial lung
disease, complete vision loss in the left eye, and retroperitoneal fibrosis. Serologic workup revealed elevated inflammatory
markers, IgG4 and IgG1 levels, and hypocomplementemia. A tissue biopsy helped us establish a definitive diagnosis of IgG4RD and initiate treatment with glucocorticoids to prevent further progression of kidney disease and other end-organ damage.
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Immunoglobulin G4–related disease (IgG4-RD) is a chronic
multisystem inflammatory disorder. The exact pathogenesis
of the disease is not well understood and is a relatively recent
diagnostic entity.1,2 Some of the characteristic features
include tissue fibrosis of involved organ systems, infiltration
of lymphocytes, and IgG4-secreting plasma cells in the
affected tissues. Serum immunoglobulin G4 levels may be
elevated during an acute flare of the disease, although the
levels may be within normal limits.1,3 Another characteristic
feature of the disease is the development of mass lesions in
multiple organ systems, which may have the appearance of
tumors. IgG4-RD can affect almost any tissue in the body,
and the fibrosing inflammatory processes in the affected sites
may lead to organ dysfunction.1,2,4 Frequently, the disease
responds well to glucocorticoids. Untreated IgG4-RD may
lead to progression of organ dysfunction with the potential
for irreversible damage. As such, early diagnosis for timely
treatment is imperative in all symptomatic patients with
IgG4-RD.3-5

pneumoconiosis was noted to have rising serum creatinine
levels on outpatient evaluation and was referred for hospitalization for further evaluation of his progressive kidney
disease.
He reported generalized weakness, fatigue, nausea, occasional vomiting, anorexia, and onset of a petechial skin rash
that involved both lower extremities including the anterior
tibial regions, lateral aspects of the upper thighs, and the
inguinal areas. He had intermittent bilateral ankle edema and
bilateral pedal neuropathy for about 3 weeks prior to the presentation. He reported having mild vague chronic lower
abdominal discomfort for several months prior to the presentation. He had been taking an over-the-counter analgesic
powder containing aspirin, acetaminophen, and caffeine
daily until 5 months prior to presentation when he was
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Case Presentation
A 66-year-old male with a past medical history of well-
controlled hypertension, hypothyroidism, and coal worker’s
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Table 1. Trend in Serum Creatinine Level Months Prior to the Current Admission.
Serum creatinine level

Timeline

1.8 mg/dL
3.7 mg/dL
6 mg/dL
3 mg/dL

6 months before admission
5 months before admission
3.5 months before admission
3 months before admission

9 mg/dL

At the time of current hospital admission

hospitalized for pneumonia and was advised to discontinue
taking the analgesic powder. After he discontinued taking the
analgesic powder, he started taking 2 tablets of over-thecounter ibuprofen daily for his chronic headache and low
back pain.
He experienced unilateral visual disturbances in his left
eye 3 months prior to admission, and on ophthalmological
evaluation, he was diagnosed with posterior scleritis and was
prescribed oral corticosteroids for 1 month. Despite completing the corticosteroid course, his visual disturbances continued to progress with complete loss of vision in his left eye.
He preferred no further workup or treatment for his left
visual loss.
Review of systems was further remarkable for chronic
cough with occasional production of small amounts of brown
sputum, chronic exertional dyspnea, occasional episodes of
epistaxis, and unintentional weight loss of about 35 to 40
pounds in the preceding several months. For these pulmonary symptoms, he received several antibiotic courses over a
6-month period.
His family history was notable for renal disease of uncertain etiology in his sister. He used smokeless tobacco in the
form of tobacco dipping, but no alcohol or illicit drug use
was reported. He had occupational exposure to fine particulate matter as a coal mine worker for several years. He had
no history of any episodes of pancreatitis, hepatitis, or elevated transaminases. Vital signs were within normal limits.
Physical examination revealed petechial rash over both
shins, upper lateral aspect of both thighs and in the inguinal
areas, and trace bilateral ankle edema. He was hemodynamically stable with no uremic symptoms with a good urine
output, and a functional capacity more than 4 metabolic
equivalents.
A trend in his serum creatinine level months prior to current admission is described in Table 1. Workup 6 months
prior to current admission is shown in Table 2.
At the time of current admission, his serum creatinine was
at 9.0 mg/dL with a non-anion gap metabolic acidosis and
hyperphosphatemia due to kidney disease. Plasma potassium
levels were noted to be in the normal range. He had a baseline hemoglobin in the range of 11 to 12 g/dL, and his white
blood cell count was chronically elevated for the preceding 6
months in the range of 10 500 to 22 900/µL. Elevated lymphocytes, granulocytes, and monocytes were found on the

Remarks
Monitored outpatient
Monitored outpatient—patient missed his follow-up appointment
Monitored outpatient—patient missed his follow-up appointment
Patient was receiving corticosteroid treatment course for his
ocular disease
Current hospitalization for further evaluation

Table 2. Laboratory Evaluation Findings 6 Months Prior to
Current Admission.
Test
Rheumatoid factor
Antinuclear antibodies
Erythrocyte sedimentation rate
C-reactive protein
Rapid plasma reagin
Antineutrophil cytoplasmic
antibody
Bronchoscopy with lung biopsy

Result
Positive
Positive with a titer of 1:320
90 mm/h
60 units
Negative
Negative
Histopathology negative
for any malignancy, acidfast organisms, and other
microbiological agents

differential. Blood cultures were negative. Electrocardiogram
did not show any significant abnormalities. Urinalysis
revealed no red blood cells, white blood cells, casts, or proteinuria. Urine sodium level was 72 mEq/L, and urine creatinine level was 50 mg/dL. Hepatitis C antibody was reactive,
while viral load was undetectable; hepatitis B surface antigen was negative. Further workup revealed low complement
levels with low C3 and C4, positive rheumatoid factor, negative antinuclear antibody, negative antineutrophil cytoplasmic antibody, negative cryoglobulin, elevated free kappa and
lambda light chains, elevated erythrocyte sedimentation rate,
and C-reactive protein (Table 3). IgG subclass evaluation is
described in Table 4.
Chest X-ray demonstrated progression of interstitial lung
changes, which prompted noncontrast computed tomography (CT) scan of the lungs, which revealed multiple significantly enlarged mediastinal and right hilar lymph nodes,
worsened from the previous examination with changes of
chronic obstructive pulmonary disease and reticular interstitial changes. Significant worsening of infiltrates predominantly in both upper lobes and right lower lobe with a small
right effusion were seen (Figure 1).
Renal ultrasound was unremarkable. CT scan of abdomen
and pelvis without intravenous contrast revealed increasing
infiltrates within both lung bases and pleural thickening when
compared with radiographic imaging 6 months previously,
mild retroperitoneal fibrosis with prominent soft tissue in the
aortocaval region below the renal vessels, nonobstructing left
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Table 3. Serologic Workup Findings of Our Patient During the
Current Admission.
Test
Complement C3
Complement C4
Kappa-S
Lambda-S
Kappa:Lambda ratio
c-ANCA
p-ANCA
Atypical p-ANCA
RF qualitative
ANA
Cryoglobulins
CRP
ESR
Tuberculosis
QuantiFERON

Results
2 mg/dL
49 mg/dL
432.1 mg/L
218.5 mg/L
1.98
<1:20 titer
<1:20 titer
<1:20 titer
Positive, 1:16 titer
Negative, less than
1:40 titer
Negative
38.6 mg/L
>140
Negative

Reference range
14-44 mg/dL
82-167 mg/dL
3.3-19.4 mg/L
5.7-26.3 mg/L
0.26-1.65
Neg: <1:20 titer
Neg: <1:20 titer
Neg: <1:20 titer
Negative
Less than 1:40
Negative
0-5 mg/L
Less than 20 mm/h
Negative

Figure 1. Mediastinal and hilar lymphadenopathy, reticular
interstitial changes.

Abbreviations: ANCA, antineutrophil cytoplasmic antibody; RF, rheumatoid factor; ANA, antinuclear antibody; CRP, C-reactive protein; ESR,
erythrocyte sedimentation rate.

Table 4. Laboratory Evaluation of Our Patient’s IgG Subclass
Levels During the Current Admission.
IgG subclass
IgG1
IgG2
IgG3
IgG4

Results

Reference range

2076 mg/dL
242 mg/dL
87 mg/dL
341 mg/dL

248-810 mg/dL
130-555 mg/dL
15-102 mg/dL
2-96 mg/dL

Abbreviation: IgG, immunoglobulin G.

renal calculi, and hepatosplenomegaly without portal venous
enlargement (Figures 2 and 3).
Nephropathological evaluation of the renal biopsy was
significant for a finding of IgG4-related tubulointerstitial
nephritis consistent with IgG4-RD. There was no evidence
of an immune complex–mediated or active glomerulonephritis. Light microscopy of the renal biopsy showed diffuse
plasma rich inflammatory cell infiltrate throughout fibrotic
interstitium with a focal storiform pattern, scattered lymphocytes, and few eosinophils within the inflammatory infiltrate.
Immunohistochemical staining for IgG4 was strongly positive for staining within the interstitial plasma cell infiltrate.
Immunofluorescence microscopy showed granular IgG
staining along tubular basement membranes.
He was administered a single bolus of 500 mg intravenous methylprednisolone and was discharged on prednisone
40 mg by mouth daily with dose tapering to be determined on
future outpatient visits.
At his outpatient nephrology follow-up visit a month after
discharge, his serum creatinine levels showed a steady

Figure 2. Retroperitoneal fibrosis with prominent soft tissue in
the aortocaval region below the renal vessels.

decline to 3.0 mg/dL. There was also a decline in inflammatory markers with C-reactive protein at 6.5 mg/L and erythrocyte sedimentation rate at 43 mm/h while on prednisone 40
mg by mouth daily. He will be followed closely in the outpatient setting for further prednisone dose tapering and renal
function monitoring.

Discussion
Patients with IgG4-RD may be asymptomatic or may have
only mild symptoms. Frequently, patients are found to have
mass lesions from the IgG-RD which can easily be mistaken
for other conditions; thus, patients may be misdiagnosed for

4

Figure 3. Retroperitoneal fibrosis.

months to years.4-7 It is quite possible that mass lesions from
IgG4-RD can be misdiagnosed as malignancy.4 Multiple
organ systems may be involved, and patients may develop
vision loss, hearing deficits, pleural effusion, constrictive
pericarditis, and chronic kidney disease. Constitutional
symptoms such as weight loss and fatigue have been
described and were noted in our patient. Kidney involvement
in IgG4-RD may manifest in several different ways, including ureteral obstruction from retroperitoneal fibrosis to the
tubulointerstitial disease with plasma cell infiltration seen in
this patient.6,8-11 Patients with retroperitoneal fibrosis may
complain of vague pain.11,12 The patient in the case did complain of vague lower abdominal pain for several months prior
to current presentation and reported gradual worsening of his
lower abdominal pain that led to a diagnosis of retroperitoneal fibrosis on CT imaging, but there were no signs of
hydronephrosis or obstructive uropathy. Another way that
the kidneys can become injured in IgG4-RD is from tubulointerstitial infiltration with IgG4-secreting plasma cells.
A tissue diagnosis is required for the definitive diagnosis
of IgG4-RD. A tissue sample from an affected site classically
shows histopathological features of tissue infiltration by
lymphocytes, IgG-positive plasma cells, a storiform pattern
of fibrosis, or obliterative phlebitis. Eosinophilic tissue infiltration or nonobliterative phlebitis may be observed on histopathologic examination as well.5,6,13-16
Given the protean manifestations of IgG4-RD, it has
recently been postulated that a variety of other clinical conditions may represent IgG4-RD.13 These disorders include type
1 autoimmune pancreatitis, Riedel’s thyroiditis, Mikulicz’s
disease, pseudotumor at different sites, Küttner’s tumor,
inflammatory aortic aneurysm, fibrosing mediastinitis, retroperitoneal fibrosis, idiopathic interstitial nephritis, or aortitis.13-15 Elevated serum IgG4 levels as seen in this patient are
neither very sensitive nor specific for the diagnosis.5,8,16
The pathogenesis of hypocomplementemia observed in
IgG4-RD is unclear.12,14,16 There is some indication that
hypocomplementemia is a feature of IgG4-RD and that

Journal of Investigative Medicine High Impact Case Reports
the hypocomplementemia is driven by other IgG subclasses. For instance, our patient was noted to have elevated IgG1 and IgG4 levels with low levels of C3 and C4.
It might thus suggest that elevated IgG subclasses may
play a role in activating the complement system. There
have been reports suggesting that patients in general with
hypocomplementemia may have elevated IgG subclasses
when compared with patients who have normal complement levels.1,14,16,17 Hypocomplementemia may have some
relationship with elevations in other IgG subclasses
besides IgG4 in the disease. However, in the current literature, there is no clear understanding of which complement activation systems are involved in IgG4-RD and if
they are associated with the disease pathogenesis. More
research is needed to explore the association between the
disease pathogenesis and hypocomplementemia, if any,
which may provide more clues toward management in
refractory cases.1,12,14-17
The current standard of treatment is to induce and maintain remission of symptomatic active IgG4-RD. Early diagnosis and treatment are required to prevent continued
inflammation, fibrosis, and irreversible organ dysfunction.
A tissue diagnosis of IgG4-RD helped us with timely goaldirected treatment with glucocorticoids resulting in marked
improvement in kidney function, thereby preventing progression to end-stage renal disease. Currently, initial therapy
for active disease is glucocorticoids, though optimal initial
dose and tapering schedule are unknown. It may lead to
improvement in symptoms and in radiologic and laboratory
markers.15,18,19 Disease recurrence after glucocorticoid taper
is common. If patients have severe disease manifestations
leading to organ dysfunction or failure or have a high risk of
relapse, then a maintenance therapy becomes essential,
which may be with a low dose of glucocorticoid or a steroidsparing agent.16,18-20

Conclusion
The disease pathogenesis, epidemiology, incidence, and
prevalence of IgG4-RD is not well known in the medical
literature as it is a relatively recently discovered pathological entity. Early diagnosis and prompt treatment are of great
importance to reduce the risk of progression and the development of permanent organ damage. Our patient was found
to have hypocomplementemic tubulointerstitial nephritis
leading to progressive renal failure. A correlation of the
entire clinical presentation and laboratory and radiographic
findings with the exclusion of other serious etiologies should
be made, and if there is any suspicion of the IgG4-RD, a
prompt tissue biopsy of the affected site must be made for
early confirmatory diagnosis and treatment.
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